Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is multiple sclerosis an autoimmune disease?

J R Gulcher1, T Vartanian, K Stefansson

  • 1Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.

Clinical Neuroscience (New York, N.Y.)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain age prediction using deep learning uncovers associated sequence variants.

Nature communications·2019
Same author

Rare and Common Variants Conferring Risk of Tooth Agenesis.

Journal of dental research·2018
Same author

Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence.

Molecular psychiatry·2017
Same author

15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia.

Translational psychiatry·2017
Same author

A rare missense mutation in CHRNA4 associates with smoking behavior and its consequences.

Molecular psychiatry·2016
Same author

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence.

Translational psychiatry·2015
Same journal

Cardiovascular autonomic dysfunction in parkinsonian patients.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Visuo-cognitive dysfunctions in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Gastrointestinal dysfunction in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Respiratory function in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Neurophysiology of sensorimotor integration in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Imaging of nonmotor symptoms in Parkinson syndromes.

Clinical neuroscience (New York, N.Y.)·2000
See all related articles

While multiple sclerosis (MS) is often viewed as autoimmune, this review finds the autoimmune hypothesis unproven. Further research into alternative multiple sclerosis pathogenesis is warranted.

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Central Nervous System (CNS) Disorders

Background:

  • Multiple sclerosis (MS) is widely classified as an autoimmune disease in medical literature.
  • This prevailing view heavily influences MS research and treatment strategies.
  • Current treatments often involve immunosuppressive agents, some with significant side effects.

Purpose of the Study:

  • To critically examine the evidence supporting the autoimmune hypothesis of MS pathogenesis.
  • To evaluate the impact of the autoimmune hypothesis on MS research and patient care.
  • To highlight the need for exploring alternative etiological possibilities for MS.

Main Methods:

  • Review of existing scientific literature and evidence for autoimmune mechanisms in MS.

Related Experiment Videos

  • Analysis of the influence of the autoimmune hypothesis on research directions.
  • Assessment of the outcomes of immunosuppressive therapies in MS patients.

    • Main Results:

    • The evidence supporting MS as a purely autoimmune disease remains inconclusive.
    • The autoimmune hypothesis has directed research, potentially overlooking other contributing factors.
    • Some MS treatments based on the autoimmune model have yielded benefits but also caused harm.

    Conclusions:

    • The hypothesis that multiple sclerosis is an autoimmune disease is plausible but not definitively proven.
    • Continued investigation into non-autoimmune etiological factors for MS is crucial.
    • A comprehensive understanding of MS pathogenesis requires considering all potential mechanisms.